Who
Eric Weinberg
Officer
Company insider
Files Form 4 as: Chief Commercial Officer, RxSight; V.P. Mktg & Prof. Affairs, Intralase.
In numbers
- Trades disclosed
- 73
- Buys
- 6
- Sells
- 7
- Bought
- $515K
- Sold
- $2.3M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 28 Apr 2006
- Last trade
- 15 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Sep 2026filed 16 Sep 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code M | $153K35,168 at $4.34 | filing |
| 15 Sep 2026filed 16 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —35,168 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code M | —35,168 at $0.00 | filing |
| 15 Sep 2026filed 16 Sep 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code M | $153K35,168 at $4.34 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —87,437 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —93,984 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —95,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —92,200 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —87,437 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —95,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —92,200 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —50,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —125,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —65,742 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —82,608 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —59,483 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,258 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code A | —93,984 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —50,000 | filing |
| 5 Sep 2026filed 9 Sep 2026 | RXST RxSightoption or derivative · Medical Devices | SEC FORM 4 Code D | —125,000 | filing |
News
Eric Weinberg's Lawyer Calls Him a 'Creep' as Rape Trial Beginslamag.com · 2 Oct 2026Who is Eric Weinberg? Scrubs writer rape trial begins in LA; 8 women to testify as explicit photos take center stagehindustantimes.com · 2 Oct 2026'Scrubs' Writer Eric Weinberg Goes on Trial for Rape and Sex Assaultvariety.com · 1 Oct 2026Exclusive | Famed producer Eric Weinberg faces life in sexual assault trialnypost.com · 1 Oct 2026RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing RulesRXST · manilatimes.net · 24 Oct 2026Analyzing AxoGen (NASDAQ:AXGN) & RxSight (NASDAQ:RXST)RXST · themarketsdaily.com · 22 Oct 2026RxSight Appoints Eye Care Industry Leaders to Drive Commercial TransformationRXST · manilatimes.net · 19 Oct 2026
4 headlines in the last 90 days name Eric Weinberg; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.